Component: (Network and Table)
Network
00500 - Statement - Consolidated Statements of Cash Flows
(http://www.itg.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Condensed Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Condensed Consolidated Statements of Cash Flows
 
 
 
Cash flows from Operating Activities:
 
 
 
Net (loss) income
(25,918,000) 
91,570,000  
50,892,000  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
43,523,000  
44,151,000  
49,384,000  
Deferred income tax (benefit) expense
(15,755,000) 
12,912,000  
(4,979,000) 
Provision for doubtful accounts
67,000  
496,000  
(801,000) 
Non-cash share based compensation
25,620,000  
16,667,000  
15,359,000  
Gain on sale of investment research operations
(21,000) 
(107,699,000) 
 
Changes in operating assets and liabilities:
 
 
 
Cash restricted or segregated under regulations and other
(3,048,000) 
55,000  
(616,000) 
Deposits with clearing organizations
1,420,000  
(1,113,000) 
38,347,000  
Securities owned, at fair value
3,048,000  
5,973,000  
(5,489,000) 
Receivables from brokers, dealers and clearing organizations
871,317,000  
(404,818,000) 
211,491,000  
Receivables from customers
(11,738,000) 
53,909,000  
(37,238,000) 
Accounts payable and accrued expenses
13,034,000  
(18,978,000) 
27,389,000  
Payables to brokers, dealers and clearing organizations
(853,923,000) 
366,462,000  
(203,805,000) 
Payables to customers
2,681,000  
(775,000) 
(5,075,000) 
Securities sold, not yet purchased, at fair value
(2,397,000) 
(5,102,000) 
6,162,000  
Income taxes receivable/payable
(11,889,000) 
1,710,000  
6,194,000  
Excess tax benefit from share-based payment arrangements
(880,000) 
(2,982,000) 
(1,278,000) 
Other, net
(59,000) 
(3,692,000) 
(3,397,000) 
Net cash provided by operating activities
35,082,000  
 
48,746,000  
 
142,540,000  
 
Cash flows from Investing Activities:
 
 
 
Proceeds from sale of investment research operations, net of deal costs
6,125,000  
111,240,000  
 
Investment in unconsolidated affiliates
  
(2,669,000) 
Acquisition of subsidiaries, net of acquired cash
  
(18,293,000) 
Capital purchases
(21,315,000) 
(11,905,000) 
(13,798,000) 
Capitalization of software development costs
(24,617,000) 
(26,003,000) 
(26,331,000) 
Net cash used in investing activities
(39,807,000) 
 
73,332,000  
 
(61,091,000) 
 
Cash flows from Financing Activities:
 
 
 
Repayments of long term debt
(6,200,000) 
(8,820,000) 
(12,551,000) 
(Repayments of) proceeds from borrowing under short-term bank loans
(9,784,000) 
3,573,000  
4,821,000  
Debt issuance costs
(810,000) 
 
(1,200,000) 
Excess tax benefit from share-based payment arrangements
880,000  
2,982,000  
1,278,000  
Common stock issued
3,743,000  
1,742,000  
96,000  
Common stock repurchased
(22,112,000) 
(42,046,000) 
(48,165,000) 
Dividends paid
(9,124,000) 
(7,030,000) 
 
Shares withheld for net settlements of share-based awards
(6,795,000) 
(8,978,000) 
(6,231,000) 
Net cash used in financing activities
(50,202,000) 
 
(58,577,000) 
 
(61,952,000) 
 
Effect of exchange rate changes on cash and cash equivalents
2,251,000  
(8,058,000) 
(6,184,000) 
Net increase (decrease) in cash and cash equivalents
(52,676,000) 
 
55,443,000  
 
13,313,000  
 
Cash and cash equivalents - beginning of year
330,653,000  
275,210,000  
261,897,000  
Cash and cash equivalents - end of period
277,977,000  
 
330,653,000  
 
275,210,000  
 
Supplemental cash flow information:
 
 
 
Interest paid
6,116,000  
3,607,000  
3,979,000  
Income taxes paid
9,880,000  
15,098,000  
11,909,000  
Supplemental disclosure of non-cash investing and financing activities:
 
 
 
Capital expenditures funded by financing from seller
 
3,606,000